This series of four fact sheets emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge.
You May Also Be Interested In
This fact sheet (3 of 4) talks about what pregnant women with opioid use disorder should know about and expect after the birth of their baby. This resource includes information about neonatal abstinence syndrome, baby’s needs after birth, and do’s and don’ts for understanding and responding to baby’s needs.
This fact sheet (4 of 4) addresses the care of women with opioid use disorder (OUD) and care of their babies after pregnancy. This resource includes information on managing OUD, caring for baby, and do’s and don’ts for creating a healthy environment at home.
This fact sheet (1 of 4) gives pregnant women with opioid use disorder (OUD) helpful steps to ensure they have a healthy pregnancy and a healthy baby. This resource includes things to know about OUD and pregnancy, and do's and don'ts to keep mother and baby healthy during pregnancy.
This fact sheet (2 of 4) addresses how treatment of pregnant women with opioid use disorder (OUD) can help women have a healthy pregnancy and a healthy baby. This resource describes managing OUD with a treatment plan that includes medicines and counseling.
Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence
This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.
This report presents a set of substance use and mental health indicators from population and treatment facility-based data sets. It provides point-in-time and trend data reflecting the status and progress of improving key behavioral health indicators.